You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Improved Treatment of Colorectal Cancer with CF10

    SBC: Deep Creek Pharma, LLC            Topic: 102

    PROJECT SUMMARY Decades of modulating the anti-cancer activity of fluoropyrimidine drugs (FPs) thru schedule optimization, biochemical modulation, and drug combinations have provided a significant, but limited, survival advantage for treating colorectal cancer (CRC) patients with locally advanced or metastatic disease (mCRC). However, outcomes remain poor for patients with mCRC and since targeted ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  2. CN-105 Improves Functional Outcome After Intracranial Hemorrhage

    SBC: AegisCN LLC            Topic: 106

    Annually, approximately 100,000 patients in the USA suffer from intracerebral hemorrhage (ICH), which is associated with high mortality rates and poor long-term cognitive and physical recovery. At present, no pharmacological therapies have been demonstrated to improve functional outcomes after ICH. However, we have successfully demonstrated that CN-105, a pentapeptide derived from the receptor bin ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability

    SBC: BIOCHIP LABS, INC.            Topic: NHLBI

    PROJECT SUMMARY Deformability and non-adherence are the most intrinsic biorheological properties of red blood cells (RBCs), as they play a critical role in modulating RBC perfusion through the microvasculature. In acquired or inherited blood disorders, such as sickle cell disease (SCD), these two interrelated properties are pathologically altered. SCD is an autosomal recessive disorder associated ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Synthetic Aperture Radar(SAR) Image Generation Data Augmentation

    SBC: ETEGENT TECHNOLOGIES, LTD.            Topic: DTRA21B001

    Machine learning algorithms have demonstrated performance on par with or superior to human analysts on large datasets when sufficient training data is available.  For military applications obtaining sufficient, truthed data is always a challenge.  Three approaches have been used for measured data collections to support sensor exploitation programs: coordinated collections, turntable measurements ...

    STTR Phase II 2023 Department of DefenseDefense Threat Reduction Agency
  5. A dual-acting small molecule for the treatment of type 1 diabetes

    SBC: ASAKE BIOTECHNOLOGY, LLC            Topic: NIDDK

    Project Summary: Over 1.5 million Americans suffer from type 1 diabetes (T1D), an autoimmune disorder involving insulin, a hormone that is essential for blood glucose regulation and overall energy metabolism. When first diagnosed with T1D, it is estimated that the patient’s insulin has been reduced by 70-90%. By this point, the immune system has already targeted and destroyed a vast majority of ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  6. SciDAP: Scientific Data Analysis Platform

    SBC: DATIRIUM LLC            Topic: NHGRI

    The recent proliferation of next-generation sequencing (NGS) - based methods for the analysis of expression, chromatin and protein-DNA interactions has created tremendous opportunities for gaining insights into biology, health, and disease. However, analysis of the data requires computational expertise that many biologists do not possess. Hence, when dealing with genomics data, majority of biologi ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  7. Endothelialized microfluidic assays for emerging therapies in sickle cell disease

    SBC: BIOCHIP LABS, INC.            Topic: NHLBI

    TBD

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  8. Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood

    SBC: Redbud Labs, Inc.            Topic: 400

    ABSTRACTMicroscale simulations have been applied to a number of complex microfluidic systems and biological applications, but existing methods are limited in the scale and scope of problems that are addressable. Thermodynamically constrained averaging theory (TCAT) is an established approach that can be used to formulate customized macroscale models that are consistent with microscale physics and ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  9. MegaTrans – human transporter machine learning models

    SBC: COLLABORATIONS PHARMACEUTICALS INC            Topic: 400

    Summary Being able to predict interactions with important human transporters would be of value to new drug design to avoid compounds that interact with them and cause undesirable side effects. Conversely, some drug transporters can be used for targeting molecules to specific organs and this may have considerable utility. Understanding the interactions of novel drugs, natural products and environme ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  10. Phase II: In-field analysis of trace U and Pu by electrochemical pre-concentration

    SBC: AWAREABILITY TECHNOLOGIES, LLC            Topic: DTRA20B003

    The Defense Threat Reduction Agency (DTRA) needs a capability to collect and provide immediate presumptive analysis of radiological/nuclear samples of concern at the source of collection. Such in-field technologies should be capable of detecting and identifying trace quantities of elements and/or chemicals containing plutonium (Pu) and uranium (U), with a focus on chemicals specific to the nuclear ...

    STTR Phase II 2022 Department of DefenseDefense Threat Reduction Agency
US Flag An Official Website of the United States Government